ANT-2681

N/A

Report date: 2022/01/14 13:23:58
NMEQIDP

Base Information

Drug NameANT-2681
Drug Alias NameANT-2681MEM-ANT-2681
ClassificationSmall molecules
Mechanisms of ActionBeta Lactamase inhibitors
TargetsBeta Lactamase
Therapy Area/IndicationsGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAntabio SAS
China Registration ClassN/A

Develop Information

Active CompaniesAntabio SAS
Inactive CompaniesN/A
Active IndicationsGram-Negative Bacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A